{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:27:11Z","timestamp":1794436031350,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rcl.2026.01.012","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:38:58Z","timestamp":1773261538000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Screening in the MR Imaging Era"],"prefix":"10.1016","volume":"64","author":[{"given":"Rory L.","family":"Cochran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh G.","family":"Harisinghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rcl.2026.01.012_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022. CA A","volume":"72","author":"Siegel","year":"2022","journal-title":"Cancer J Clinicians"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1016\/j.rcl.2026.01.012_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European Study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.rcl.2026.01.012_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate-cancer mortality at 11 years of Follow-up","volume":"366","author":"Schr\u00f6der","year":"2012","journal-title":"N Engl J Med"},{"issue":"9959","key":"10.1016\/j.rcl.2026.01.012_bib8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of screening for prostate cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.012_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.rcl.2026.01.012_bib11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.rcl.2026.01.012_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial","volume":"319","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of Follow-up","volume":"104","author":"Andriole","year":"2012","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"10071","key":"10.1016\/j.rcl.2026.01.012_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.rcl.2026.01.012_bib15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.012_bib16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"Van Der Leest","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.rcl.2026.01.012_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-Targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.rcl.2026.01.012_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.rcl.2026.01.012_bib20","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.rcl.2026.01.012_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","article-title":"Results after four years of screening for prostate cancer with PSA and MRI","volume":"391","author":"Hugosson","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00345-011-0801-1","article-title":"Familial risk and familial survival in prostate cancer","volume":"30","author":"Hemminki","year":"2012","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.012_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.012_bib24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.euo.2024.01.015","article-title":"Magnetic resonance imaging\u2013based prostate cancer screening in carriers of pathogenic germline mutations: interim results from the initial screening round of the prostate cancer genetic risk evaluation and screening study","volume":"7","author":"Amini","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.rcl.2026.01.012_bib25","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","article-title":"Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants","volume":"55","author":"Wang","year":"2023","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.rcl.2026.01.012_bib26","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.rcl.2026.01.012_bib27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"issue":"10437","key":"10.1016\/j.rcl.2026.01.012_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part II: considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.012_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","article-title":"NCCN guidelines\u00ae insights: prostate cancer early detection, version 1.2023: featured updates to the NCCN guidelines","volume":"21","author":"Moses","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.012_bib33","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.jacr.2023.02.010","article-title":"ACR appropriateness criteria\u00ae pretreatment detection, surveillance, and staging of prostate cancer: 2022 update","volume":"20","author":"Akin","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.rcl.2026.01.012_bib34","unstructured":"American College of Radiology: PI-RADS: Prostate Imaging \u2013 Reporting and Data System. Version 2.1 2019."},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt","year":"2025","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.012_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070280","article-title":"Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol","volume":"13","author":"Asif","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.012_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/Ultrasound fusion\u2013guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.012_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CU9.0000000000000116","article-title":"Learning curve for magnetic resonance imaging\/ultrasound fusion prostate biopsy in detecting prostate cancer using cumulative sum analysis","volume":"17","author":"Xu","year":"2023","journal-title":"Curr Urol"},{"key":"10.1016\/j.rcl.2026.01.012_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2023.04.017","article-title":"Intra-practice urologist-level variation in targeted fusion biopsy outcomes","volume":"177","author":"Dhir","year":"2023","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.rcl.2026.01.012_bib41","doi-asserted-by":"crossref","first-page":"894.e19","DOI":"10.1016\/j.crad.2019.03.026","article-title":"A multicentre assessment of prostate MRI quality and compliance with UK and international standards","volume":"74","author":"Burn","year":"2019","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","article-title":"Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway","volume":"20","author":"Barrett","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"11","key":"10.1016\/j.rcl.2026.01.012_bib43","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","article-title":"PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI","volume":"34","author":"De Rooij","year":"2024","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.rcl.2026.01.012_bib44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jacr.2024.04.008","article-title":"Improving prostate MR image quality in practice\u2014initial results from the ACR prostate MR image quality improvement collaborative","volume":"21","author":"Purysko","year":"2024","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.012_bib45","article-title":"Accelerating prostate diffusion-weighted MRI using a guided denoising convolutional neural network: retrospective feasibility study","volume":"2","author":"Kaye","year":"2020","journal-title":"Radiology: Artif Intell"},{"issue":"7","key":"10.1016\/j.rcl.2026.01.012_bib46","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s00261-021-02964-6","article-title":"Novel deep learning-based noise reduction technique for prostate magnetic resonance imaging","volume":"46","author":"Wang","year":"2021","journal-title":"Abdom Radiol"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiol.204097","article-title":"Deep learning reconstruction of diffusion-weighted MRI improves image quality for prostatic imaging","volume":"303","author":"Ueda","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2026.01.012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111017","article-title":"Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality","volume":"166","author":"Lee","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rcl.2026.01.012_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110953","article-title":"Accelerated diffusion-weighted imaging of the prostate using deep learning image reconstruction: a retrospective comparison with standard diffusion-weighted imaging","volume":"165","author":"Ursprung","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rcl.2026.01.012_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinimag.2024.110341","article-title":"Minimizing prostate diffusion weighted MRI examination time through deep learning reconstruction","volume":"117","author":"Cochran","year":"2025","journal-title":"Clin Imag"},{"key":"10.1016\/j.rcl.2026.01.012_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinimag.2025.110681","article-title":"Comparing prostate diffusion weighted images reconstructed with a commercial deep-learning product to a deep learning phase corrected model at 1.5 T","volume":"130","author":"Cochran","year":"2026","journal-title":"Clin Imag"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00330-022-08978-y","article-title":"A concurrent, deep learning\u2013based computer-aided detection system for prostate multiparametric MRI: a performance study involving experienced and less-experienced radiologists","volume":"33","author":"Labus","year":"2022","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.rcl.2026.01.012_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.012_bib54","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230750","article-title":"Evaluation of a cascaded deep learning\u2013based algorithm for prostate lesion detection at biparametric MRI","volume":"311","author":"Lin","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2026.01.012_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinimag.2025.110484","article-title":"Impact of artificial intelligence assisted lesion detection on radiologists\u2019 interpretation at multiparametric prostate MRI","volume":"122","author":"Nakrour","year":"2025","journal-title":"Clin Imag"},{"key":"10.1016\/j.rcl.2026.01.012_bib56","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.32399","article-title":"Evaluating artificial intelligence\u2013assisted prostate biparametric MRI interpretation: an international multireader study","author":"Gelikman","year":"2025","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000003960","article-title":"Artificial intelligence improves the ability of physicians to identify prostate cancer extent","volume":"212","author":"Mota","year":"2024","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.012_bib58","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240140","article-title":"Requirements for AI development and reporting for MRI prostate cancer detection in biopsy-naive men: PI-RADS steering Committee, version 1.0","volume":"315","author":"Turkbey","year":"2025","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.012_bib59","article-title":"External validation of a previously developed deep learning\u2013based prostate lesion detection algorithm on paired external and In-House biparametric MRI scans","volume":"6","author":"Yilmaz","year":"2024","journal-title":"Radiology: Imaging Cancer"},{"issue":"10438","key":"10.1016\/j.rcl.2026.01.012_bib60","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0140-6736(24)00912-7","article-title":"Prostate cancer UK launches the TRANSFORM trial","volume":"403","author":"Burki","year":"2024","journal-title":"Lancet"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838926000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838926000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:58:25Z","timestamp":1794434305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033838926000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0033838926000126"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2026.01.012","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Cancer Screening in the MR Imaging Era","name":"articletitle","label":"Article Title"},{"value":"Radiologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcl.2026.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}